• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • SillaJen and NCI partner to develop new colorectal cancer treatment pharmaceutical-technology
    August 21, 2017
    Korean-based SillaJen has entered a cooperative research and development agreement (CRADA) with the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), US, to develop a new combination therapy for colorectal cancer (CRC).

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service